Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CAPMATINIB vs CARBAMAZEPINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CAPMATINIB vs CARBAMAZEPINE: Safety Overview

Metric CAPMATINIB CARBAMAZEPINE
Total FAERS Reports 2,301 24,577
Deaths Reported 583 2,156
Death Rate 25.3% 8.8%
Hospitalizations 388 9,608
Average Patient Age 71.9 yrs 50.1 yrs
% Female Patients 53.9% 61.8%
FDA Approval Date May 6, 2020 Approved Prior to Jan 1, 1982
Manufacturer Novartis Pharmaceuticals Corporation REMEDYREPACK INC.
Route ORAL ORAL
Marketing Status Prescription Prescription